WJ460

CAS No. 1415251-36-3

WJ460( —— )

Catalog No. M26864 CAS No. 1415251-36-3

WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 83 In Stock
5MG 82 In Stock
10MG 139 In Stock
25MG 226 In Stock
50MG 333 In Stock
100MG 485 In Stock
200MG 668 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WJ460
  • Note
    Research use only, not for human use.
  • Brief Description
    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
  • Description
    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.(In Vitro):WJ460 dose-dependently blocks breast cancer cell invasion through Collagen I(IC50: 43.37 nM in MDA-MB-231 and 36.40 nM in BT549 cells).(In Vivo):In a spontaneous metastasis model, WJ460 inhibits angiogenesis, breast tumor growth, and spontaneous metastasis .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Adrenocorticotropic hormone (ACTH)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1415251-36-3
  • Formula Weight
    460.59
  • Molecular Formula
    C27H28N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCCCCC=1C=CC=CC1)C2=CC=CC(=C2)C3SCC(=O)N3C=4C=CC=CC4OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Francesco Iuliano, et al. Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation.
molnova catalog
related products
  • V2 receptor (V2R) a...

    c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.

  • FAPI-2

    FAPI-2 is a specific inhibitor of fibroblast-activated protein based on the radiotracer FAP labeling. It has anticancer activity and can be used in the study of pancreatic cancer.

  • [Asn1,Val5]-Angioten...

    [Asn1,Val5]-Angiotensin II